Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Amyloid blood biomarker detects Alzheimer's disease.

Nabers A, Perna L, Lange J, Mons U, Schartner J, Güldenhaupt J, Saum KU, Janelidze S, Holleczek B, Rujescu D, Hansson O, Gerwert K, Brenner H.

EMBO Mol Med. 2018 Apr 6. pii: e8763. doi: 10.15252/emmm.201708763. [Epub ahead of print]

2.

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.

Janelidze S, Pannee J, Mikulskis A, Chiao P, Zetterberg H, Blennow K, Hansson O.

JAMA Neurol. 2017 Dec 1;74(12):1492-1501. doi: 10.1001/jamaneurol.2017.2814.

PMID:
29114726
3.

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.

Skillbäck T, Delsing L, Synnergren J, Mattsson N, Janelidze S, Nägga K, Kilander L, Hicks R, Wimo A, Winblad B, Hansson O, Blennow K, Eriksdotter M, Zetterberg H.

Neurobiol Aging. 2017 Nov;59:1-9. doi: 10.1016/j.neurobiolaging.2017.06.028. Epub 2017 Jul 11.

PMID:
28779628
4.

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).

Vanderstichele H, Demeyer L, Janelidze S, Coart E, Stoops E, Mauroo K, Herbst V, François C, Hansson O.

Alzheimers Res Ther. 2017 Jun 6;9(1):40. doi: 10.1186/s13195-017-0265-7.

5.

Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines.

Ventorp F, Bay-Richter C, Nagendra AS, Janelidze S, Matsson VS, Lipton J, Nordström U, Westrin Å, Brundin P, Brundin L.

J Parkinsons Dis. 2017;7(2):263-273. doi: 10.3233/JPD-171068.

6.

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.

Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K; Swedish BioFINDER study.

Neurology. 2017 Mar 7;88(10):930-937. doi: 10.1212/WNL.0000000000003680. Epub 2017 Feb 8.

7.

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.

Janelidze S, Hertze J, Nägga K, Nilsson K, Nilsson C; Swedish BioFINDER Study Group, Wennström M, van Westen D, Blennow K, Zetterberg H, Hansson O.

Neurobiol Aging. 2017 Mar;51:104-112. doi: 10.1016/j.neurobiolaging.2016.11.017. Epub 2016 Dec 5.

8.

Plasma tau in Alzheimer disease.

Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E, Palmqvist S, Baker D, Tan Hehir CA, Jeromin A, Hanlon D, Song L, Shaw LM, Trojanowski JQ, Weiner MW, Hansson O, Blennow K; ADNI Investigators.

Neurology. 2016 Oct 25;87(17):1827-1835. Epub 2016 Sep 30.

9.

CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice.

Barzilay R, Ventorp F, Segal-Gavish H, Aharony I, Bieber A, Dar S, Vescan M, Globus R, Weizman A, Naor D, Lipton J, Janelidze S, Brundin L, Offen D.

J Mol Neurosci. 2016 Dec;60(4):548-558. Epub 2016 Sep 13.

PMID:
27619521
10.

Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes.

Vanderstichele HM, Janelidze S, Demeyer L, Coart E, Stoops E, Herbst V, Mauroo K, Brix B, Hansson O.

J Alzheimers Dis. 2016 May 31;53(3):1121-32. doi: 10.3233/JAD-160286.

11.

Plasma β-amyloid in Alzheimer's disease and vascular disease.

Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A, Song L, Hanlon D, Tan Hehir CA, Baker D, Blennow K, Hansson O.

Sci Rep. 2016 May 31;6:26801. doi: 10.1038/srep26801.

12.

The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson's disease and healthy controls.

Hagell P, Westergren A, Janelidze S, Hansson O.

Qual Life Res. 2016 Oct;25(10):2571-2577. doi: 10.1007/s11136-016-1318-2. Epub 2016 May 19.

PMID:
27198749
13.

Increased CSF biomarkers of angiogenesis in Parkinson disease.

Lattanzi S, Silvestrini M, Verbeek MM, Mollenhauer B, Lindqvist D, Janelidze S, Hansson O.

Neurology. 2016 May 3;86(18):1747-8. doi: 10.1212/WNL.0000000000002667. No abstract available.

PMID:
27164652
14.

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.

Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, van Westen D, Stomrud E, Minthon L, Blennow K; Swedish BioFINDER study group, Hansson O.

Ann Clin Transl Neurol. 2016 Jan 1;3(3):154-65. doi: 10.1002/acn3.274. eCollection 2016 Mar.

15.

The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.

Ventorp F, Barzilay R, Erhardt S, Samuelsson M, Träskman-Bendz L, Janelidze S, Weizman A, Offen D, Brundin L.

J Affect Disord. 2016 Mar 15;193:349-54. doi: 10.1016/j.jad.2015.12.069. Epub 2016 Jan 6.

PMID:
26796235
16.

Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.

Janelidze S, Hertze J, Zetterberg H, Landqvist Waldö M, Santillo A, Blennow K, Hansson O.

Ann Clin Transl Neurol. 2015 Nov 20;3(1):12-20. doi: 10.1002/acn3.266. eCollection 2016 Jan.

17.

Increased CSF biomarkers of angiogenesis in Parkinson disease.

Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE, van Westen D, Londos E, Cenci MA, Hansson O.

Neurology. 2015 Nov 24;85(21):1834-42. doi: 10.1212/WNL.0000000000002151. Epub 2015 Oct 28.

18.

Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice.

Bay-Richter C, Janelidze S, Sauro A, Bucala R, Lipton J, Deierborg T, Brundin L.

J Neuroinflammation. 2015 Sep 4;12:163. doi: 10.1186/s12974-015-0387-4.

19.
20.

Pro-inflammatory cytokines reduce the proliferation of NG2 cells and increase shedding of NG2 in vivo and in vitro.

Wennström M, Janelidze S, Bay-Richter C, Minthon L, Brundin L.

PLoS One. 2014 Oct 6;9(10):e109387. doi: 10.1371/journal.pone.0109387. eCollection 2014.

21.

Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.

Janelidze S, Suchankova P, Ekman A, Erhardt S, Sellgren C, Samuelsson M, Westrin A, Minthon L, Hansson O, Träskman-Bendz L, Brundin L.

Acta Psychiatr Scand. 2015 Apr;131(4):269-78. doi: 10.1111/acps.12339. Epub 2014 Sep 24.

PMID:
25251027
22.

Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.

Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O.

Brain Behav Immun. 2013 Oct;33:183-9. doi: 10.1016/j.bbi.2013.07.007. Epub 2013 Jul 31.

23.

Connecting inflammation with glutamate agonism in suicidality.

Erhardt S, Lim CK, Linderholm KR, Janelidze S, Lindqvist D, Samuelsson M, Lundberg K, Postolache TT, Träskman-Bendz L, Guillemin GJ, Brundin L.

Neuropsychopharmacology. 2013 Apr;38(5):743-52. doi: 10.1038/npp.2012.248. Epub 2012 Dec 3.

24.

Inflammation in suicidality: implications for novel treatment options.

Janelidze S, Brundin L.

Mod Trends Pharmacopsychiatry. 2013;28:188-202. doi: 10.1159/000346085. Epub 2013 Feb 27. Review.

PMID:
25224900
25.

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.

Janelidze S, Ventorp F, Erhardt S, Hansson O, Minthon L, Flax J, Samuelsson M, Traskman-Bendz L, Brundin L.

Psychoneuroendocrinology. 2013 Jun;38(6):853-62. doi: 10.1016/j.psyneuen.2012.09.010. Epub 2012 Oct 9.

PMID:
23062672
26.

Aldosterone synergizes with peripheral inflammation to induce brain IL-1β expression and depressive-like effects.

Bay-Richter C, Hallberg L, Ventorp F, Janelidze S, Brundin L.

Cytokine. 2012 Dec;60(3):749-54. doi: 10.1016/j.cyto.2012.08.016. Epub 2012 Sep 13.

PMID:
22981168
27.

Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence.

Zhang Y, Träskman-Bendz L, Janelidze S, Langenberg P, Saleh A, Constantine N, Okusaga O, Bay-Richter C, Brundin L, Postolache TT.

J Clin Psychiatry. 2012 Aug;73(8):1069-76. doi: 10.4088/JCP.11m07532. Epub 2012 Jul 10.

PMID:
22938818
28.

Changes in behaviour and cytokine expression upon a peripheral immune challenge.

Bay-Richter C, Janelidze S, Hallberg L, Brundin L.

Behav Brain Res. 2011 Sep 12;222(1):193-9. doi: 10.1016/j.bbr.2011.03.060. Epub 2011 Apr 2.

PMID:
21466824
29.

CSF biomarkers in suicide attempters--a principal component analysis.

Lindqvist D, Janelidze S, Erhardt S, Träskman-Bendz L, Engström G, Brundin L.

Acta Psychiatr Scand. 2011 Jul;124(1):52-61. doi: 10.1111/j.1600-0447.2010.01655.x. Epub 2010 Dec 28.

PMID:
21198458
30.

Cytokine levels in the blood may distinguish suicide attempters from depressed patients.

Janelidze S, Mattei D, Westrin Å, Träskman-Bendz L, Brundin L.

Brain Behav Immun. 2011 Feb;25(2):335-9. doi: 10.1016/j.bbi.2010.10.010. Epub 2010 Oct 15.

PMID:
20951793
31.

Decreased aldosterone in the plasma of suicide attempters with major depressive disorder.

Hallberg L, Westrin A, Isaksson A, Janelidze S, Träskman-Bendz L, Brundin L.

Psychiatry Res. 2011 May 15;187(1-2):135-9. doi: 10.1016/j.psychres.2010.07.038. Epub 2010 Aug 24.

PMID:
20797799
32.

Exercise-induced release of cytokines in patients with major depressive disorder.

Hallberg L, Janelidze S, Engstrom G, Wisén AG, Westrin A, Brundin L.

J Affect Disord. 2010 Oct;126(1-2):262-7. doi: 10.1016/j.jad.2010.02.133. Epub 2010 Mar 27.

PMID:
20347489
33.

Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.

Janelidze S, Bexell D, Badn W, Darabi A, Smith KE, Fritzell S, Gunnarsson S, Milos P, Bengzon J, Salford LG, Siesjö P, Visse E.

J Immunother. 2009 Jul-Aug;32(6):593-601. doi: 10.1097/CJI.0b013e3181a95148.

PMID:
19483650
34.

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, Hansson O, Björkqvist M, Träskman-Bendz L, Brundin L.

Biol Psychiatry. 2009 Aug 1;66(3):287-92. doi: 10.1016/j.biopsych.2009.01.030. Epub 2009 Mar 6.

PMID:
19268915
35.

Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.

Smith KE, Fritzell S, Badn W, Eberstål S, Janelidze S, Visse E, Darabi A, Siesjö P.

Int J Cancer. 2009 Feb 1;124(3):630-7. doi: 10.1002/ijc.23986.

36.

Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.

Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P.

Scand J Immunol. 2007 Mar;65(3):289-97.

37.

Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma.

Smith KE, Janelidze S, Visse E, Badn W, Salford L, Siesjö P, Darabi A.

Int J Cancer. 2007 Jan 1;120(1):75-80.

38.

Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.

Janelidze S, Enell K, Visse E, Darabi A, Salford LG, Siesjö P.

Immunol Lett. 2005 Nov 15;101(2):193-201.

PMID:
16002150
39.

Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNgamma-secreting rat glioma cells.

Johansson AC, Hegardt P, Janelidze S, Visse E, Widegren B, Siesjö P.

J Neuroimmunol. 2002 Feb;123(1-2):135-43.

PMID:
11880158
40.

Protein aggregation after focal brain ischemia and reperfusion.

Hu BR, Janelidze S, Ginsberg MD, Busto R, Perez-Pinzon M, Sick TJ, Siesjö BK, Liu CL.

J Cereb Blood Flow Metab. 2001 Jul;21(7):865-75.

PMID:
11435799
41.

Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia.

Janelidze S, Hu BR, Siesjö P, Siesjö BK.

Neurobiol Dis. 2001 Feb;8(1):147-54.

PMID:
11162248
42.

Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type?

Ouyang YB, He QP, Li PA, Janelidze S, Wang GX, Siesjö BK.

Neurochem Res. 2000 May;25(5):661-7.

PMID:
10905628
43.

Role and mechanisms of secondary mitochondrial failure.

Siesjö BK, Elmér E, Janelidze S, Keep M, Kristián T, Ouyang YB, Uchino H.

Acta Neurochir Suppl. 1999;73:7-13. Review.

PMID:
10494335
44.

Supplemental Content

Loading ...
Support Center